Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Conexeu Sciences Inc.CNXU · Entity 6454 | Director | May 14, 2026 | May 15, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Conexeu Sciences Inc.
Report date May 14, 2026 · Filed May 15, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 433,323 |
Reported balance
After 2026-05-14 transaction · row 1
1 source rowRow 1 · 2026-05-14 · Grant · Acquired 11,175 · Balance 433,323 F1: The reported shares were issued to the Reporting Person at a deemed price of $4.00 per share for total compensation of $44,700 owing to the Reporting Person for services rendered to the issuer, which is payable in shares. No price was paid for the shares. |
Filing footnotes · ownership attribution and instrument terms
F1: The reported shares were issued to the Reporting Person at a deemed price of $4.00 per share for total compensation of $44,700 owing to the Reporting Person for services rendered to the issuer, which is payable in shares. No price was paid for the shares.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 14, 2026 Filed May 15, 2026 22:43 UTC | Conexeu Sciences Inc. CNXU · Entity 6454 | GrantCommon Stock | 11,175 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-26-002732 · form4.xml · nonDerivative · entry 1 Lorenc Zbigniew Paul · CIK 0002127734 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 433,323 F1 · price: The reported shares were issued to the Reporting Person at a deemed price of $4.00 per share for total compensation of $44,700 owing to the Reporting Person for services rendered to the issuer, which is payable in shares. No price was paid for the shares. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.